|
Video: What is a Stock Split?
|
|
Skystar Bio-Pharmaceutical, through its subsidiaries in the People's Republic of China (PRC) and Xi'an Tianxing Bio-Pharmaceutical Co., Limited (Xi'an Tianxing), is engaged in the research, development, production, marketing, and sales of veterinary healthcare and medical care products. Xi'an Tianxing and Co.'s subsidiary, Skystar Biotechnology (Jingzhou) Co., Limited primarily manufacture and distribute of veterinary drugs. Co. has four product lines: micro-organism, which includes 16 products; veterinary medicine for poultry and livestock, which includes 145 products; feed additives, which includes 16 products; and bio-pharmaceutical veterinary vaccine, which includes 10 products. According to our SKBI split history records, SKBI has had 3 splits. | |
|
SKBI (SKBI) has 3 splits in our SKBI split history database. The first split for SKBI took place on May 18, 2009. This was a 1 for 10 reverse split, meaning for each 10 shares of SKBI owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split. SKBI's second split took place on November 17, 2009. This was a 2 for 1 split, meaning for each share of SKBI owned pre-split, the shareholder now owned 2 shares. For example, a 100 share position pre-split, became a 200 share position following the split. SKBI's third split took place on February 16, 2006. This was a 1 for 400 reverse split, meaning for each 400 shares of SKBI owned pre-split, the shareholder now owned 1 share. For example, a 200 share position pre-split, became a 0.5 share position following the split.
When a company such as SKBI splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business. When a company such as SKBI conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the SKBI split history from start to finish, an original position size of 1000 shares would have turned into 0.5 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into SKBI shares, starting with a $10,000 purchase of SKBI, presented on a split-history-adjusted basis factoring in the complete SKBI split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/22/2014 |
|
End date: |
07/14/2017 |
|
Start price/share: |
$6.08 |
|
End price/share: |
$0.06 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.01% |
|
Average Annual Total Return: |
-76.06% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$98.74 |
|
Years: |
3.23 |
|
|
|
Date |
Ratio |
05/18/2009 | 1 for 10 | 11/17/2009 | 2 for 1 | 02/16/2006 | 1 for 400 |
|
|